Pfizer IIT-Delhi Innovation and IP Program

We posted about healthcare incubation initiative by Pfizer and IIT Delhi here, http://pharmaliterati.blogspot.in/2015/11/pfizer-iit-delhi-collaborate-for.html

An incubation accelerator co-created by Pfizer and FITT at IIT-Delhi.  The Pfizer IIT Delhi Innovation and IP Program (PIDIIP) will provide funding support of upto 50 lakhs to propel India's healthcare innovations from idea to IP.

The Pfizer-IIT Delhi Innovation and IP Program is a collaborative incubation accelerator - co-created by Pfizer and Foundation for Innovation and Technology Transfer (FITT) at the Indian Institute of Technology Delhi (IIT Delhi).

The Program will provide - funding, resources, expertise and infrastructure – to propel India’s healthcare innovations from idea to IP.

Pfizer funding through this program will provide an unencumbered grant of upto Rs. 50 lakhs to each innovator – selected through an appropriately drawn up process.

Patents obtained as a result of the incubation shall belong to the innovators, who will be free to commercialize them as they desire.

Two components of the Pfizer IIT Delhi Innovation & IP Program (PIDIIP)

1. For innovators seeking comprehensive support to translate their healthcare ideas into new business opportunities, the Program provides:
• Resident incubation at IIT Delhi’s bio-incubator for a period of up to 2 years.
• Funding of upto INR 50 lakhs for each innovator to take ideas through proof of concept to IP.
• Mentoring support from IIT Delhi’s faculty and FITT nominated experts.
• Access to infrastructure, prototyping laboratories and space for setting up an office.
• IP search and filing services.
• Guidance from Pfizer’s global experts.
• Access to venture capitalists and other industry linkages
2. For innovators who already have a proof of principle /concept and are only looking for IP related support, the program provides:
• Access to IP counselling services at FITT.
• Funding support to cover patenting expenses.